Chantix Lawyer | Chantix Settlements

Missouri Couple Joins Alabama Chantix MDL No. 2092

Perry Larkin | January 17th, 2013

Chantix Gavel SmashTo date, more than 2,500 plaintiffs who have filed a Chantix lawsuit have had their cases centralized in the product liability litigation against manufacturer Pfizer. Chantix is meant to help people to quit smoking. In these cases, the plaintiffs allege that the defendant marketed a potentially dangerous drug and failed to provide sufficient warning as to the possible side effects.

Residents of Missouri John and Robin Eddington joined the multidistrict litigation (MDL) no. 2092 alleging severe side effects suffered by John Eddington including vivid dreams, severe depression and agitation and an eventual suicide attempt. The MDL is located in the U.S. District Court for the Northern District of Alabama. They filed the short form complaint on September 27, 2012; this incorporates allegations and references made in the master long form complaint.

Research shows danger of Chantix side effects

Chantix is also known by the generic name varenicline. Research has led to the suspicion that the medication can cause disturbing neurological side effects due to it blocking dopamine. Dopamine is the chemical that prevents depression and other issues of mental health. But this blocking also assists in stopping the addiction to nicotine. In certain patients, the Chantix side effects can be very dangerous. They have reportedly experienced thoughts of suicide, rampages, hallucinations, and paranoia.

Lawsuits allege Pfizer marketed a defective drug

The lawsuits taking part in the MDL allege that Pfizer marketed a defective drug and failed to adequately warn of the side effects. Plaintiffs in the lawsuits hope to win a judgment or gain a settlement for their injuries. Individuals who have suffered from such side effects as attempted or completed Chantix suicide are encouraged to contact an experienced attorney to discuss their options.

FDA orders a black box warning placed on Chantix package

Chantix was approved by the FDA in 2006. Since then, it has been the subject of multiple controversies due to the dangerous problems that have been linked to its use. The range of side effects reported include: suicide ideation and attempts; depression; rage; and violent mood swings.

Thousands of patients like Eddington experienced problems because of it. Over a single 18 month period, the FDA received nearly 300 reports involving depression and suicide. As a result, in July 2009, the agency ordered a black box warning to be placed on the packaging to advise consumers of the potential “hostility, agitation, depressed mood, and suicidal thoughts or actions,” when taking Chantix.